Under construction – not a live service

Skip to content

Frontlight Research

Trial site

Onkologie UnterEms

Leer, 26789, GermanyNot linked to an institution yet

1closed trial

The trials here

What the trial at this site is about, from its registry record.

Conditions: Lung cancer

Closed trials

Active, not recruiting
A Study to Compare ABP 234 and Keytruda® (Pembrolizumab) in Participants With Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer
NCT06311721· Phase 3· Amgen· Source

Site data: EU CTIS (euclinicaltrials.eu)Updated 12 Nov 2026

Report an error

Under construction, not live – Onkologie UnterEms: trial site – Frontlight Research